Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Kemet Q4 Revenue View Unchanged - Quick Facts

RELATED NEWS
Trade KEM now with 
3/22/2012 9:24 AM ET

Kemet Corp. (KEM: Quote) Thursday said it still anticipates fourth-quarter revenue of between $205 million and $210 million, lower than last year's $261.5 million. Analysts' consensus currently sees revenues of $205.60 million. Fourth-quarter results may be expected May 10, 2012.

Further, the company forecast adjusted EBITDA for the year ending March 31, 2012 in the range of $128 million to $132 million. For fiscal 2011, Kemet had reported adjusted EBITDA of $196.1 million.

Click here to receive FREE breaking news email alerts for KEMET CORP and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
There was a mixed performance on Wall Street on Friday. Shares suffered an early decline, as investors continued to express worries about the Federal Reserve. A recovery through the rest of the day allowed the Dow to edge into positive territory by the close. The Nasdaq and S&P 500 posted fractional losses. Stocks have shown a notable move to the downside in early trading on Friday amid lingering concerns about the outlook for the Federal Reserve's asset purchase program. The major averages have slid firmly into negative territory, adding to the modest losses posted in the previous session. The major averages are currently posting notable losses, near their lows for the young session. After reporting a sharp drop in new orders for manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than anticipated in the month of April. The report said durable goods orders surged up by 3.3 percent in April after tumbling by a revised 5.9 percent in March.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.